Founded in 2012, Shandong Xinhua Pharmaceutical (USA) Inc., now d.b.a. SX Pharma, is a uniquely positioned importer and supplier of nutraceuticals, API’s, flavors, and sweeteners. It is a growing organization, with the potential to become a leading supplier in the U.S. market. The company’s history has paved a road for its success…
The parent company, Shandong Xinhua Pharmaceutical Co., Ltd., is a leading GMP and ISO certified manufacturer of APIs, intermediates, chemicals and finished dosage forms. Established in 1943, the organization has been supplying leading pharmaceutical corporations, and is currently producing over 20,000 metric tons annually. As a publically held company, it is listed on Hong Kong and Shenzhen stock exchanges.
In 2013, SX Pharma acquired East-West United Group, a competitive US importer and supplier of nutraceutical raw materials since 1986. This acquisition has provided strong leverage in the U.S. market due to key long-term relationships with leading raw material producers in China. In addition, with inventory on both the west and east coasts, the company is prepared to respond promptly to current demands.
SX Pharma possesses an excellent track-record in quality control, provides a reliable service, and offers aggressive pricing to the customer. Integrity, reliability, and efficiency are core values of the company. The organization looks forward to the opportunity of exceeding customers’ expectations.